Ottmann O - Search Results

1

Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

Topp MS, Kufer P, Gökbuget N, Goebeler M, Klinger M, Neumann S, Horst HA, Raff T, Viardot A, Schmid M, Stelljes M, Schaich M, Degenhard E, Köhne-Volland R, Brüggemann M, Ottmann O, Pfeifer H, Burmeister T, Nagorsen D, Schmidt M, Lutterbuese R, Reinhardt C, Baeuerle PA, Kneba M, Einsele H, Riethmüller G, Hoelzer D, Zugmaier G, Bargou RC. Topp MS, et al. Among authors: ottmann o. J Clin Oncol. 2011 Jun 20;29(18):2493-8. doi: 10.1200/JCO.2010.32.7270. Epub 2011 May 16. J Clin Oncol. 2011. PMID: 21576633 Clinical Trial.

2

Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunological and molecular genetic analyses.

Schardt C, Ottmann OG, Hoelzer D, Ganser A. Schardt C, et al. Among authors: ottmann og. Leukemia. 1992 May;6(5):370-4. Leukemia. 1992. PMID: 1375695

3

Interleukin-3 in the treatment of myelodysplastic syndromes.

Ganser A, Ottmann OG, Hoelzer D. Ganser A, et al. Among authors: ottmann og. Int J Clin Lab Res. 1992;22(3):125-8. doi: 10.1007/BF02591411. Int J Clin Lab Res. 1992. PMID: 1520908 Review.

4

In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells.

Eder M, Ottmann OG, Hansen-Hagge TE, Bartram CR, Falk S, Gillis S, Hoelzer D, Ganser A. Eder M, et al. Among authors: ottmann og. Blood. 1992 Jun 15;79(12):3274-84. Blood. 1992. PMID: 1596568 Free article.

5

Bone marrow findings after treatment with recombinant human interleukin-3.

Falk S, Seipelt G, Ganser A, Ottmann OG, Hoelzer D, Stutte HJ, Hübner K. Falk S, et al. Among authors: ottmann og. Am J Clin Pathol. 1991 Mar;95(3):355-62. doi: 10.1093/ajcp/95.3.355. Am J Clin Pathol. 1991. PMID: 1996545

6

Effects of recombinant human IL-7 on blast cell proliferation in acute lymphoblastic leukemia.

Eder M, Ottmann OG, Hansen-Hagge TE, Bartram CR, Gillis S, Hoelzer D, Ganser A. Eder M, et al. Among authors: ottmann og. Leukemia. 1990 Aug;4(8):533-40. Leukemia. 1990. PMID: 2388482

7

The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia.

Ganser A, Ottmann OG, Erdmann H, Schulz G, Hoelzer D. Ganser A, et al. Among authors: ottmann og. Ann Intern Med. 1989 Dec 1;111(11):887-92. doi: 10.7326/0003-4819-111-11-887. Ann Intern Med. 1989. PMID: 2683920

8

Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial.

Ottmann OG, Hoelzer D, Gracien E, Ganser A, Kelly K, Reutzel R, Lipp T, Busch FW, Schwonzen M, Heil G, et al. Ottmann OG, et al. Blood. 1995 Jul 15;86(2):444-50. Blood. 1995. PMID: 7541660 Free article. Clinical Trial.

9

Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia. A pilot study.

Ottmann OG, Ganser A, Freund M, Heil G, Hiddemann W, Heit W, Gracien E, Hoelzer D. Ottmann OG, et al. Ann Hematol. 1993 Oct;67(4):161-7. doi: 10.1007/BF01695862. Ann Hematol. 1993. PMID: 7692982 Clinical Trial.

10

Interleukin 3 and interleukin 3/GM-CSF combination therapy--clinical implications.

Ganser A, Ottmann OG, Hoelzer D. Ganser A, et al. Among authors: ottmann og. Stem Cells. 1993 Nov;11(6):465-73. doi: 10.1002/stem.5530110616. Stem Cells. 1993. PMID: 8111306 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page